Pathogenesis of the urethral syndrome in women and its diagnosis in general practice

Facial expression recognition in the broader autism phenotype: What does alexithymia have to do with it?

Cognition·2025

Positive Neutrino Masses with DESI DR2 via Matter Conversion to Dark Energy.

Physical review letters·2025

The Physiome Project and Digital Twins.

IEEE reviews in biomedical engineering·2024

Beyond pulmonary rehabilitation: can the PICk UP programme fill the gap? A randomised trial in COPD.

Pulmonology·2024

Implementation of virtual pulmonary rehabilitation during the COVID-19 pandemic: Experiences and perceptions of patients and healthcare providers.

Respiratory medicine·2024

The effect of digital interventions on related health literacy and skills for individuals living with chronic diseases: A systematic review and meta-analysis.

International journal of medical informatics·2023

The 2026 report of the Lancet Countdown on health and climate change: a decade of escalating health harms and a decisive moment for all.

Lancet (London, England)·2026

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Accessory Cavitating Uterine Masses/Malformation: An Important Differential in Women With Intractable Dysmenorrhea and Chronic Pelvic Pain Across All Ages.

The journal of obstetrics and gynaecology research·2026

Cytogenetic analysis of couples with recurrent pregnancy loss in taiwan: A retrospective study of 451cases.

Taiwanese journal of obstetrics & gynecology·2026

Efficacy of estetrol (E4) 15 mg/ drospirenone (DRSP) 3 mg combination for the treatment of dysmenorrhea in women with recurrent endometriosis and/or adenomyosis.

Taiwanese journal of obstetrics & gynecology·2026

Evaluation and Management of Syncope in Pregnancy and Postpartum.

Obstetrics and gynecology clinics of North America·2026

Common Arrhythmias in Pregnancy.

Obstetrics and gynecology clinics of North America·2026

Posterior Tibial Tendon Dysfunction in Women: Role of Hormones, Estrogen, Weight Gain, Pregnancy.

Foot and ankle clinics·2026

Pathogenesis of the urethral syndrome in women and its diagnosis in general practice

Related Experiment Videos

Related Concept Videos

Facial expression recognition in the broader autism phenotype: What does alexithymia have to do with it?

Positive Neutrino Masses with DESI DR2 via Matter Conversion to Dark Energy.

The Physiome Project and Digital Twins.

Beyond pulmonary rehabilitation: can the PICk UP programme fill the gap? A randomised trial in COPD.

Implementation of virtual pulmonary rehabilitation during the COVID-19 pandemic: Experiences and perceptions of patients and healthcare providers.

The effect of digital interventions on related health literacy and skills for individuals living with chronic diseases: A systematic review and meta-analysis.

The 2026 report of the Lancet Countdown on health and climate change: a decade of escalating health harms and a decisive moment for all.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Accessory Cavitating Uterine Masses/Malformation: An Important Differential in Women With Intractable Dysmenorrhea and Chronic Pelvic Pain Across All Ages.

Cytogenetic analysis of couples with recurrent pregnancy loss in taiwan: A retrospective study of 451cases.

Efficacy of estetrol (E4) 15 mg/ drospirenone (DRSP) 3 mg combination for the treatment of dysmenorrhea in women with recurrent endometriosis and/or adenomyosis.

Evaluation and Management of Syncope in Pregnancy and Postpartum.

Common Arrhythmias in Pregnancy.

Posterior Tibial Tendon Dysfunction in Women: Role of Hormones, Estrogen, Weight Gain, Pregnancy.

Pathogenesis of the urethral syndrome in women and its diagnosis in general practice

Related Experiment Videos

Related Concept Videos

Related Articles